+ T cells, respectively, suggests that there are unique mechanisms to establish Tfh-cell identity. In this study, we found that Tfh cells preferentially express the transcriptional coactivator Bob1. Bob1 of Tfh cells was dispensable for the expression of B-cell lymphoma-6 and the functional property of the cells for B cell help. However, upon initial immunization of foreign antigens, the percentages of Tfh cells in Bob1 −/− mice were much higher than those in wild-type (WT) mice.
Introduction
Antigen-specific humoral immune responses are established by the active interaction of B cells and T follicular helper (Tfh) cells, a distinctive subset of effector CD4 + T cells [1, 2] . Tfh cell sub-of Tfh cells. Since other types of effector CD4 + T cells such as Th1 cells, Th2 cells, Treg cells, and Th17 cells are regulated by Blimp-1, a Bcl-6 antagonist, it is thought that a unique mechanism specifically operated by Bcl-6 defines the identity of a Tfh cell lineage [3] . Extensive investigations have revealed that the transcription regulators MAF and BATF support the function of Bcl-6 in Tfh cells to produce IL-4 and IL-21 [4] . Accumulating evidence from studies on circulating Tfh cells have indicated undesirable immune responses by memory Tfh cells in patients with disorders including systemic lupus erythematosus and rheumatoid arthritis [5, 6] . However, the mechanisms regulating human Tfh cells have not been fully elucidated.
In this study, we compared the transcriptome of Tfh cells residing in germinal centers (GCs-Tfh cells) of the tonsils to that of CD4 + T cells of the thymus as a control and dissected unidentified regulators of Tfh cells. The results showed that B-cell-specific octamer binding protein 1 (Bob1, OBF1, OCA-B) was highly expressed in Tfh cells. Bob1 is known as a transcriptional coactivator associated with Oct1 or Oct2 through recognition of POU domains and it assists B-cell activation to produce antigen-specific antibodies [7, 8] . Analysis of tonsillar lymphocytes and Bob1-deficient mice revealed that Bob1 regulates proliferation and cell death mediated by CD3, and thereby the numerical frequency of Tfh cells would be maintained. Further investigation focusing on Bob1 would lead to a better understanding of a program of functional resolution of Tfh cells and the pathogenesis of autoimmunity and allergy associated with specific antibody production.
Results

Expression of Bob1 in Tfh cells and Th-cell subsets
Since the first discovery of Tfh cells as CXCR5 + T cells in GCs of lymphoid follicles, Tfh cells have been shown to comprise subsets residing in lymphoid tissues and peripheral blood [9] [10] [11] . To find a molecule(s) regulating human Tfh cells, microarray analysis was initially performed in archetypal GC-Tfh cells (CD3 + CD4 + CXCR5 hi PD-1 hi ) of the tonsils and single-positive naïve CD4 + T cells (CD3 + CD4 + CD8 − ) of the thymus as a control ( Fig. 1A and Supporting Information Fig. 1 ). A total of 611 and 319 genes were extracted as genes preferentially upand downregulated, respectively, in Tfh cells compared to their levels in naïve CD4 + T cells, (Supporting Information Table 1 and 2). In each altered gene set, genes that are known to be expressed in Tfh cells (Bcl-6, MAF, CXCR5, CXCL13, IL-21) and in naïve CD4 + T cells (KLF2, IL7R, LEF1, TMSB10, CCR7) were included in the 50 highest upregulated genes. In this study, seven genes of which expression in Tfh cells has not been reported previously were selected, and their transcripts were confirmed by RT-PCR in purified lymphocytes of the tonsils and thymus (Fig. 1B) . Within candidate genes for which expression was validated, we focused on Bob1 of a transcriptional coactivator, because Bob1 regulates GC formation of B cells [7] . As assessed by quantitative RT-PCR analysis, the transcription levels of Bob1 Fig. 1A) , and the identity of each population was further examined by ICOS expression (Supporting Information Fig. 1B Fig. 3A 
Apoptotic activity and proliferative capacity of Bob1
−/−
Tfh cells in vitro
CD4
+ T cells control their own cell number to ensure effector and memory functions though proliferation and cell death as well after major histocompatibility complex (MHC) class II based stimulation from APCs [12] . Thus, we next conducted in vitro studies to evaluate responses of Bob1 −/− Tfh cells to TCR stimulation.
For culture up to 3 days, stimulation with anti-CD3 mAb reduced the number of Bob1 +/+ Tfh cells due to activation-induced cell death, whereas Bob1 −/− Tfh cells were refractory to the stimulation and maintained their number (Fig. 4A ). These cells were further assessed by experiments using annexin V and 7-aminoactinomycin D to detect apoptotic cells. 
Discussion
Here, we reported a role of Bob1, which was originally identified as a B-cell regulator to produce high-affinity antibodies, in the [19, 20] . Collectively, the results indicate that Bob1 is not necessary for the expression of functional molecules such as Bcl-6, which exert B-cell help producing antibodies, even though Bob1 of Tfh cells acts as a controller of cell numbers. The mechanism by which the number of Tfh cells is controlled remains controversial. Experimental evidence obtained by using mice lacking CD40 or MHC class II on B cells suggests that Tfh cell differentiation is independent of B cells [21] . Furthermore, Tfh cell differentiation can occur early after virus infection through processes without B cells [18] . According to these findings, it is understandable that Tfh cells were detected even in Bob1 −/− mice, which are unable to produce antigen-specific B cells upon immunization. Several studies have suggested that T-B cell interactions are required for the differentiation of Tfh cells [22] [23] [24] .
A reduction of Tfh cells in Bob1
−/− mice has been reported in a mouse model during influenza infection and in a sanroque mouse model of systemic lupus, which manifests constitutive activation of ICOS signaling by a point mutation of Rouquin1 [20, 25] . These results seem to be contradictory to our observation of the accumulation of Tfh cells in Bob1 at high and low levels, respectively, as found in this study [27] . Thus, greater proliferative capacity and lower apoptotic susceptibility of Bob1 −/− Tfh cells imply that the level of Bob1 expression is likely to be involved in such functional features. Within GCs of lymphoid follicles, Bob1 hi GC-Tfh cells afford antibodyproducing capacity to GC-B cells with high expression levels of MHC class II molecules [28] . Since appropriate numbers of GCTfh cells are required for optimal differentiation of GC-B cells, Bob1 may restrict GC-Tfh cell numbers for efficient differentiation of B cells during the active interaction of GC-B cells and GC-Tfh cells [29, 30] . In this context, Bob1 of GC-Tfh cells might play a role in decreasing sensitivities to further activation and proliferation signals through TCR in order to execute their own function. Our RT-PCR experiments for transcription factors and cytokines characteristic to Th1, Th2, and Th17 cells demonstrated that Bob1 seemed not to be involved in a regulation of functional balance of these T-cell subsets. On the other hand, the subtle accumulation of T-bet-expressing cells within Bob1 −/− CD4 + cells was detected by intracellular FACS analysis. It has been reported that Th1 cells share a certain transitional stage and have an overlapped phenotype during their development from naïve CD4 + T cells [31] . Further investigations would be needed to clarify whether Bob1 can be involved in regulation of a Th1 population size.
Currently, the precise mechanism by which Bob1 regulates proliferative and apoptotic responses of Tfh cells is not known. Bob1 forms a ternary complex with POU proteins of the ubiquitous factor Oct-1 or the B-cell-specific factor Oct-2 on conserved octamer motifs, suggesting that a gene(s) regulated by a Bob1/Oct1 complex might be responsible for TCR/CD3 signaling of Tfh cells. The Bob1 protein is able to interact with the cytoplasmic protein of Syk, which is a nonreceptor-type tyrosine kinase [32] . The proximal components of TCR form a multiprotein complex including ZAP-70/Syk and Lck, and Bob1 in Tfh cells can thus modulate TCR signalosomes including Syk to appropriately adjust cellular responses [33, 34] . While it is known that Bob1 and Bcl-6 can upregulate Syk in B cells, further investigation is needed to determine the role of Bob1 and Bcl-6 in the control of Syk in Tfh cells [35, 36] .
In summary, our study revealed that Bob1 participates in a unique endogenous mechanism to possibly limit TCR-mediated expansion of Tfh cells. It has been reported that patients with systemic lupus erythematosus or allergic diseases have an increased frequency of ICOS + CD4 + T cells, suggesting a pathological expansion of Tfh cells [37] [38] [39] . Because of the functional importance of Tfh cells, a mechanism regulating Tfh cell numbers is a critical issue for the understanding of initial and recall humoral responses and Tfh-cell related disorders such as autoimmunity, allergy, and cancer [40, 41] . Further investigations of Bob1 may shed new light on a mechanism regulating immune homeostasis through the control of Tfh cells.
Materials and methods
Tissues
Surgically resected specimens of tonsils were obtained from patients admitted to Sapporo Medical University Hospital. Thymus tissues were obtained from surgical specimens of patients with cardiovascular disorders who underwent surgery in the Hokkaido Medical Center for Child Health and Rehabilitation. Some of the tissues were stored in OCT compound (Sakura, Tokyo, Japan) at -80°C for frozen tissue sections. All tissues were obtained after receiving informed consent and with the approval of the institutional review boards of Sapporo Medical University and the Hokkaido Medical Center for Child Health and Rehabilitation.
Mice and immunization
All experiments using mice were performed in accordance with the institutional guidelines of Sapporo Medical University for the care and use of animals. Bob1-deficient mice and OT-II mice were purchased from Jackson Laboratory. By crossing these strains, we obtained Bob1 −/− OT-II mice. C57BL/6 mice used as control mice and C57BL/6 Ly5.1-congenic mice expressing CD45.1 were obtained from Sankyo Laboratory (Tokyo, Japan) and RIKEN Bioresource Center (Ibaraki, Japan), respectively. All of the mice were maintained in a specific pathogen-free animal facility of Sapporo Medical University. Age-matched (6-12 weeks) and sexmatched mice from each group, which were simultaneously raised in the same environment at the facility, were used for the experiments. Mice were immunized by intraperitoneal administration of 200 μL of 10% SRBCs in PBS or 100 μg of ovalbumin (OVA) in alum adjuvant. 
Microarray analysis
PCR
Total RNA extracted by TRIZOL reagent was reverse transcribed using a High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). The primer pairs used in this study are summarized in Supporting Information Table 3 . Quantitative PCR was performed with a Step One Real-Time PCR System of Assayon-Demand probes according to the instructions of the manufacturer (Applied Biosystems). The levels of expression of target genes were calculated using CT and comparative methods after normalization to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression.
Antibodies
Anti-human mAbs including APC-anti-CD3 (UCHT1), FITC-anti-CD3 (UCHT1), APC-Cy7-anti-CD4 (RPA-T4), PE-anti-CD8 (SK1),
, and APCCy7-anti-CD19 (SJ25C1) (BD Biosciences) and anti-mouse mAbs including PE-Cy7-anti-CD3 (145-2C11), PerCP-Cy5.5-anti-CD4 (RM4-5), PE-anti-B220 (RA3-682), PE-anti-Bcl-6 (K112-91), PE-anti-T-bet (4B10), PE-anti-GATA3 (L50-823), PE-antiRORγt (Q31-378) (BD Bioscience), APC-anti-PD-1 (29.F1A12), FITC-anti-CXCR5 (L138D7), and Pacific Blue-anti-CD45.2 (104) (Biolegend) were used for flow cytometry. For immunohistochemistry, we used anti-human Abs including Alexa Fluor 647-anti-CD4 (MT310), mouse anti-Bcl6 (P1F6; Nichirei, Tokyo, Japan), and rabbit anti-Bob1 pAb (C-20; Santa Cruz Biotechnology) for staining of human tonsils and we used hamster anti-mouse CD3 (500A2; Life Technologies) and biotin-PNA visualized by streptavidin-PE (Vector Laboratory) for staining of mouse spleens.
Flow cytometry and cell sorting
Human tonsil and thymus tissues were mechanically disrupted and lymphocytes in single cell suspensions were prepared by density gradient centrifugation with Lymphoprep (Axis-Shield). Mouse total spleen cells were prepared by lysing red blood cells with 0.84% NH 4 Cl. Subsequently, the cells were subjected to standard staining with specific surface markers for flow cytometry as previously described [42] . The cells were analyzed using FACSCanto II and FACSAria II for careful cell sorting (BD Biosciences).
In each experiment, samples were analyzed for singlet events with doublet discrimination, and the purity of FACS-sorted cells reached 95% after validation by reanalysis with FACSCanto II. The cells were also analyzed by intracellular staining for the expression of transcription factors according to the protocol of the Transcription Factor Buffer Set (BD Biosciences). Data were examined by using FACSDiVA software (BD Biosciences).
Immunohistochemical analysis
Immunohistochemistry was conducted as described previously [42] . In brief, tissue sections were stained with primary Abs in a moisture box at 4°C overnight and subsequently reacted with secondary goat pAbs conjugated to Alexa Fluor dyes (Invitrogen). Tissues slides were analyzed using an immunofluorescence microscope (IX71; Olympus) or a laser confocal microscope with image examiner software (LSM780; Carl Zeiss).
Western blot analysis
Protein expression analyses were performed using Western blot assay of whole cell extracts according to previously described procedures [42] .
Gene transfection
The human Bob1 open reading frame was amplified by PCR from the Bob1 cDNA clone (pF1KB7532; Promega) and ligated into the upstream region of the internal ribosomal entry site of pIRES2-ZsGreen1 lentivirus vector (Takara, Tokyo, Japan), resulting in Bob1-IRES2-ZsGreen1 recombinant vector. Lentiviral particles were prepared in 293T cells with Lenti-X HTX packaging system and used for transfection (Clontech). Prior to transfection, FACS-sorted human naïve CD4 + T cells were stimulated with anti-CD3 (OKT3) and anti-CD28 mAbs (15E8) obtained from Miltenyi Biotech in serum-free AIM-V medium (Invitrogen) containing 50 μg/mL streptomycin and 100 U/mL penicillin. After 48-h incubation, cells were transfected using RetroNectin (Takara).
Adoptive transfer of lymphocytes
Total CD4 + T cells were isolated from spleen cells of Bob1 RPMI 1640 medium (Invitrogen) supplemented with 10% FCS, 50 μg/mL streptomycin, and 100 U/mL penicillin was used in all experiments, and all experiments were performed at 37°C in a humidified atmosphere with 5% carbon dioxide.
Detection of apoptosis and cell proliferation
The apoptotic state of cells was assessed by staining with annexin V-FITC (ImmunoChemistry Technologies) and 7-aminoactinomycin D (BD Biosciences) according to the manufacturer's protocols. For evaluating proliferative activities, cells were labeled with 5 μM CSFE (Fluka) in PBS for 15 min at 37°C and examined by flow cytometry.
Statistical analysis
Results are expressed as means and SD. The unpaired Student's t-test was used to compare experimental groups with p < 0.05 considered significant.
